Avalo Therapeutics, Inc. ($AVTX)
Sullivan Christopher Ryan โ Chief Financial Officer
Shares
12,394
Price
$9.88
Total Value
$122,452.72
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Sullivan Christopher Ryan |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Sep 16, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Sep 18, 2026 |
| Shares Purchased | 12,394 |
| Price per Share | $9.88 |
| Total Value | $122,452.72 |
| Shares Owned After | 52,294 |
| Derivative | No |
| Accession Number | 0001810417-26-000023 |
| Document | View SEC Filing |